N,N-Dimethylglycine → 1-{4-[3-({1-[Bis-(4-chlorophenyl)methyl]azetidin-3-ylidene}methanesulfonylmethyl)phenyl]piperazin-1-yl}-2-dimethylaminoethanone

HRID 25232

반응식

HRID 25232 반응식
CCN=C=NCCCN(C)C.[CH3:12][N:13]([CH3:18])[CH2:14][C:15](O)=[O:16].[Cl:19][C:20]1[CH:25]=[CH:24][C:23]([CH:26]([C:48]2[CH:53]=[CH:52][C:51]([Cl:54])=[CH:50][CH:49]=2)[N:27]2[CH2:30][C:29](=[CH:31][S:32]([CH2:35][C:36]3[CH:37]=[C:38]([N:42]4[CH2:47][CH2:46][NH:45][CH2:44][CH2:43]4)[CH:39]=[CH:40][CH:41]=3)(=[O:34])=[O:33])[CH2:28]2)=[CH:22][CH:21]=1>ClCCl>[Cl:19][C:20]1[CH:21]=[CH:22][C:23]([CH:26]([C:48]2[CH:49]=[CH:50][C:51]([Cl:54])=[CH:52][CH:53]=2)[N:27]2[CH2:28][C:29](=[CH:31][S:32]([CH2:35][C:36]3[CH:37]=[C:38]([N:42]4[CH2:47][CH2:46][N:45]([C:15](=[O:16])[CH2:14][N:13]([CH3:18])[CH3:12])[CH2:44][CH2:43]4)[CH:39]=[CH:40][CH:41]=3)(=[O:33])=[O:34])[CH2:30]2)=[CH:24][CH:25]=1

참가 물질

5

반응물 3

HCID 673N,N-Dimethylglycine2회HCID 159081-Ethyl-3-(3'-dimethylaminopropyl)carbodiimideHCID 696356951-[3-({1-[Bis-(4-chlorophenyl)methyl]azetidin-3-ylidene}methanesulfonylmethyl)phenyl]piperazine

생성물 1

HCID 186687351-{4-[3-({1-[Bis-(4-chlorophenyl)methyl]azetidin-3-ylidene}methanesulfonylmethyl)phenyl]piperazin-1-yl}-2-dimethylaminoethanone수율 84.8%

시약·촉매·용매 1

HCID 6344Dichloromethane용매

실험 절차

511 mg of supported EDCI (2.5 mM), 11.5 mg of N,N-dimethylglycine and then 5 cm3 of dichloromethane are successively added, at a temperature close to 20° C., to 54 mg of 1-[3-({1-[bis-(4-chlorophenyl)methyl]azetidin-3-ylidene}methanesulfonylmethyl)phenyl]piperazine. After stirring for 24 hours at a temperature close to 20° C., 35 mg of N,N-dimethylglycine are added. After stirring for 96 hours at a temperature close to 20° C., the reaction mixture is filtered on sintered glass. The resin is rinsed with three times 2.5 cm3 of dichloromethane. The combined filtrates are washed with 10 cm3 of water, dried over magnesium sulfate, filtered and concentrated to dryness under reduced pressure (5 kPa) at a temperature close to 20° C. 53 mg of 1-{4-[3-({1-[bis-(4-chlorophenyl)methyl]azetidin-3-ylidene}methanesulfonylmethyl)phenyl]piperazin-1-yl}-2-dimethylaminoethanone are thus obtained in the form of a beige foam [1H NMR spectrum (400 MHz, (CD3)2SO-d6, δ in ppm): 2.20 (s, 6H), 2.94 (s, 3H), 3.12 (s, 2H), 3.16 (mt, 4H), 3.58 (mt, 2H), 3.68 (mt, 2H), 3.80 (mt, 2H), 4.19 (mt, 2H), 4.78 (s, 1H), 6.81 (broad d, J=8 Hz, 1H), 6.93 (broad s, 1H), 6.99 (dd, J=8 and 2.5 Hz, 1H), 7.26 (t, J=8 Hz, 1H), 7.36 (d, J=8 Hz, 4H), 7.46 (d, J=8 Hz, 4H)].

후처리

  1. customclose to 20° C.
  2. stirringAfter stirring for 96 hours at a temperature
  3. customclose to 20° C.
  4. filtrationthe reaction mixture is filtered on sintered glass
  5. washThe resin is rinsed with three times 2.5 cm3 of dichloromethane
  6. washThe combined filtrates are washed with 10 cm3 of water
  7. dry with materialdried over magnesium sulfate
  8. filtrationfiltered
  9. concentrationconcentrated to dryness under reduced pressure (5 kPa) at a temperature
  10. customclose to 20° C

출처 및 근거

ORD 기록
ord-3744df2ec649460a8c20ac0130a246e1
출처 데이터셋
uspto-grants-2005_02
특허 번호
US06858603B2

연결된 노트

불러오는 중…